National Pediatric Cancer Foundation, Inc.
National Pediatric Cancer Foundation, Inc.
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for National Pediatric Cancer Foundation, Inc.? Learn more here.
About this organization
Mission
The National Pediatric Cancer Foundation is a nonprofit organization dedicated to funding research to eliminate childhood cancer. Our focus is to find less toxic, more targeted therapies through a unique collaborative research initiative and partnership with top hospitals across the country.
About
THE NATIONAL PEDIATRIC CANCER FOUNDATION FUNDS PEDIATRIC CANCER RESEARCH WITH THE GOAL OF LEADING TO THE TREATMENT AND ELIMINATION OF PEDIATRIC CANCER WORLDWIDE.WE ACCOMPLISH OUR MISSION THROUGH OUR RESEARCH INITIATIVE, THE SUNSHINE PROJECT, AN INNOVATIVE COLLABORATION OF 23 HOSPITALS NATIONWIDE. THIS COLLABORATIVE RESEARCH MODEL IS UNIQUE AND EFFECTIVE IN ACCELERATING THE DEVELOPMENT OF NEW TREATMENTS AGAINST CHILDHOOD CANCER.SEE SCHEDULE O FOR FURTHER PROGRAM SERVICE ACCOMPLISHMENTS.IN DEVELOPING THIS COLLABORATION, THE FOUNDATION HAS BROUGHT TOGETHER SOME OF THE COUNTRY'S LEADING INVESTIGATORS AND INSTITUTIONS TO DRIVE THE PROCESS OF FINDING A CURE. INVESTIGATORS ARE PERFORMING THREE VITAL PHASES OF RESEARCH SIMULTANEOUSLY: BASIC SCIENCE, TRANSLATIONAL RESEARCH AND CLINICAL TRIALS. THESE MAJOR RESEARCH COMPONENTS NOT ONLY ALLOW DOCTORS TO IDENTIFY NEW AGENTS IN FIGHTING CANCER, BUT ALSO HELP RESEARCHERS TO UNDERSTAND THE CANCER CELLS RESPONSE TO THE DRUG. THE NATIONAL PEDIATRIC CANCER FOUNDATION IS MAKING GREAT STRIDES IN ITS MISSION TO FIND A CURE FOR CHILDHOOD CANCER.CURRENT INITIATIVES OF THE SUNSHINE PROJECT ARE AS FOLLOWS:A PHASE I TRIAL OF DOSE ESCALATION OF METFORMIN IN COMBINATION WITH VINCRISTINE, IRINOTECAN, AND TEMOZOLOMIDE IN CHILDREN WITH RELAPSED OR REFRACTORY SOLID TUMORS. PHASE II STUDY OF NAB-PACLITAXEL IN COMBINATION WITH GEMCITABINE FOR TREATMENT OF RECURRENT/REFRACTORY SARCOMA IN TEENAGERS AND YOUNG ADULTS. ADOPTIVE CELLULAR THERAPY FOLLOWING DOSE-INTENSIFIED TEMOZOLOMIDE IN NEWLY-DIAGNOSED PEDIATRIC HIGH-GRADE GLIOMAS. (PHASE 1) PHASE 1 TRIAL OF THE LSD1 INHIBITOR SP-2577 IN PATIENTS WITH RELAPSED OR REFRACTORY EWING SARCOMA.A PHASE LB/II STUDY TO EVALUATE THE SAFETY, FEASIBILITY, AND EFFICACY OF NIVOLUMAB OR NIVOLUMAB IN COMBINATION WITH AZACITIDINE IN PATIENTS WITH RECURRENT, RESECTABLE OSTEOSARCOMA. CURRENT NON TREATMENT/PRE-CLINICAL STUDIES IN 2019 CONSIST OF:PERSONALIZED MEDICINE: PEDIATRIC TOTAL CANCER CARE PROTOCOL - THIS TISSUE AND BLOOD BANKING TRIAL WAS LAUNCHED IN 2013 WITH THE FOCUS TO FURTHER PERSONALIZE MEDICINE FOR CHILDREN WITH CANCER.COMPREHENSIVE MOLECULAR PROFILING OF RARE PEDIATRIC AND YOUNG ADULT CANCERS.ROLE OF MYELOID-DERIVED SUPPRESSOR CELLS (MDSC) IN THE DEVELOPMENT OF IMMUNE TOLERANCE AFTER ALLOGENIC HEMATOPOIETIC CELL TRANSPLANTATION. (ALLOHCT)CLINICAL UTILIZATION OF COMPREHENSIVE GENETIC PROFILING FOR PEDIATRIC MALIGNANCIES.GENOMIC PROFILING OF MULTIPLE SYNCHRONOUS NEUROBLASTOMAS IN A PATIENT WITH GERMLINE PHOX2B MUTATION.GENOMIC PROFILING OF BILATERAL WILMS TUMOR THAT DEVELOPED IN INFANCY IN SIBLINGS WITH UNDERLYING GENETIC CAUSE.PRE-CLINICAL ASSESSMENT OF EXPANDED TUMOR-INFILTRATING NK CELLS IN PEDIATRIC SOFT-TISSURE SARCOMA.DEVELOPMENT OF PERSONALIZED RNA LOADED NANOPARTICLES FOR CHILDREN WITH REFRACTORY SOLID TUMORS.PRECLINICAL STUDY OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH 5-AZACYTIDINE IN MOUSE MODELS OF OSTEOSARCOMA.RATED A 4-STAR CHARITY BY CHARITY NAVIGATOR, GIVEN A GOLD LEVEL RATING BY GUIDESTAR AND RECEIVED ACCREDITATION FROM THE BBB WISE GIVING ALLIANCE. THESE ARE THE HIGHEST RATINGS A NONPROFIT CAN RECEIVE.
Interesting data from their 2020 990 filing
The purpose of the non-profit is stated in the filing as “National pediatric cancer foundation (npcf) is a nonprofit organization dedicated to funding research to eliminate childhood cancer. our focus is to fund research to find less toxic, more targeted therapies by partnering with leading hospitals nationwide.”.
Their activities were defined as: “The npcf is dedicated to funding research to eliminate childhood cancer.”.
- As per legal requirements, the non-profit's state of operation is reported as FL.
- The non-profit's address in 2020 as per the filing is 5550 WEST EXECUTIVE DRIVE SUITE 200, TAMPA, FL, 33609.
- The form of the non-profit organization shows 15 employees as of 2020.
- Is not a private foundation.
- Expenses are greater than $1,000,000.
- Revenue is greater than $1,000,000.
- Revenue less expenses is $152,760.
- The organization has 22 independent voting members.
- The organization was formed in 1991.
- The organization pays $932,785 in salary, compensation, and benefits to its employees.
- The organization pays $238,440 in fundraising expenses.
Additional Non-Profits in the area
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.